Clinical trials
Observational Klinefelter Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 5 |
| Recruiting | 4 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Aarhus | 8 |
| University of Colorado, Denver | 3 |
| Progenity, Inc. | 2 |
| dr. Laura C. G. de Graaff-Herder | 2 |
| Assiut University | 1 |
| Gulhane School of Medicine | 1 |
| Hospices Civils de Lyon | 1 |
| Lenetix Medical Screening Laboratory | 1 |
| Natera, Inc. | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Klinefelter Syndrome | 27 |
| Turner Syndrome | 11 |
| Down Syndrome | 5 |
| Trisomy 18 Syndrome | 5 |
| Trisomy 13 Syndrome | 4 |
| Cardiovascular Diseases | 3 |
| DiGeorge Syndrome | 3 |
| Disorders of Sex Development | 2 |
| Hypogonadism | 2 |
| Sex Chromosome Aberrations | 2 |
Trials
Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.